Acellera Competitors and Similar CompaniesClear all
Acellera's competitors and similar companies include 858 Therapeutics and Parallel Bio.
 858 Therapeutics 858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule medications that operate on oncology therapeutic targets, such as proteins that govern RNA and the innate immune response. |  Parallel Bio Parallel Bio (also known as Parallel Biosystems) is a technology company that develops a platform for drug and immunotherapies discovery. | ||
Founding Date | Founding Date 2006 | Founding Date 2019 | Founding Date 2020 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Stanmore, GB HQ Barcelona, ES | Locations San Diego, US HQ | Locations Watertown, US HQ |
Employees | Employees 14 | Employees 11 | Employees 268% increase |
Funding | |||
Latest funding round | Latest funding round $ 54.9k (about 11 years ago) | Latest funding round $ 60m (over 4 years ago) | Latest funding round $ 4.3m (over 3 years ago) |
Total funding raised | Total funding raised $ 54.9k | Total funding raised $ 80.1m | Total funding raised $ 4.3m |
For sources of this data, please see the company profile
View Company Profiles
858 Therapeutics
HQ
San Diego, US
Employees
11
858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule medications that operate on oncology therapeutic targets, such as proteins that govern RNA and the innate immune response.
View companyParallel Bio
HQ
Watertown, US
Employees
26↑ 8% increase
Parallel Bio (also known as Parallel Biosystems) is a technology company that develops a platform for drug and immunotherapies discovery.
View company